Kartogenin preconditioning commits mesenchymal stem cells to a precartilaginous stage with enhanced chondrogenic potential by modulating JNK and β-catenin-related pathways
- PMID: 30694703
- DOI: 10.1096/fj.201802137RRR
Kartogenin preconditioning commits mesenchymal stem cells to a precartilaginous stage with enhanced chondrogenic potential by modulating JNK and β-catenin-related pathways
Abstract
Cartilage engineering strategies using mesenchymal stem cells (MSCs) could provide preferable solutions to resolve long-segment tracheal defects. However, the drawbacks of widely used chondrogenic protocols containing TGF-β3, such as inefficiency and unstable cellular phenotype, are problematic. In our research, to optimize the chondrogenic differentiation of human umbilical cord MSCs (hUCMSCs), kartogenin (KGN) preconditioning was performed prior to TGF-β3 induction. hUCMSCs were preconditioned with 1 μM of KGN for 3 d, sequentially pelleted, and incubated with TGF-β3 for 28 d. Then, the expression of chondrogenesis- and ossification-related genes was evaluated by immunohistochemistry and RT-PCR. The underlying mechanism governing the beneficial effects of KGN preconditioning was explored by phosphorylated kinase screening and validated in vitro and in vivo using JNK inhibitor (SP600125) and β-catenin activator (SKL2001). After KGN preconditioning, expression of fibroblast growth factor receptor 3, a marker of precartilaginous stem cells, was up-regulated in hUCMSCs. Furthermore, the KGN-preconditioned hUCMSCs efficiently differentiated into chondrocytes with elevated chondrogenic gene ( SOX9, aggrecan, and collagen II) expression and reduced expression of ossific genes (collagen X and MMP13) compared with hUCMSCs treated with TGF-β3 only. Phosphokinase screening indicated that the beneficial effects of KGN preconditioning are directly related to an up-regulation of JNK phosphorylation and a suppression of β-catenin levels. Blocking and activating tests revealed that the prochondrogenic effects of KGN preconditioning was achieved mainly by activating the JNK/Runt-related transcription factor (RUNX)1 pathway, and antiossific effects were imparted by suppressing the β-catenin/RUNX2 pathway. Eventually, tracheal patches, based on KGN-preconditioned hUCMSCs and TGF-β3 encapsulated electrospun poly( l-lactic acid-co-ε-caprolactone)/collagen nanofilms, were successfully used for restoring tracheal defects in rabbit models. In summary, KGN preconditioning likely improves the chondrogenic differentiation of hUCMSCs by committing them to a precartilaginous stage with enhanced JNK phosphorylation and suppressed β-catenin. This novel protocol consisting of KGN preconditioning and subsequent TGF-β3 induction might be preferable for cartilage engineering strategies using MSCs.-Jing, H., Zhang, X., Gao, M., Luo, K., Fu, W., Yin, M., Wang, W., Zhu, Z., Zheng, J., He, X. Kartogenin preconditioning commits mesenchymal stem cells to a precartilaginous stage with enhanced chondrogenic potential by modulating JNK and β-catenin-related pathways.
Keywords: TGF-β3; chondrogenic; differentiation; endochondral ossification; tracheal defect.
Similar articles
-
Synergistic Effects of Kartogenin and Transforming Growth Factor-β3 on Chondrogenesis of Human Umbilical Cord Mesenchymal Stem Cells In Vitro.Orthop Surg. 2020 Jun;12(3):938-945. doi: 10.1111/os.12691. Epub 2020 May 28. Orthop Surg. 2020. PMID: 32462800 Free PMC article.
-
Injectable double-crosslinked hydrogels with kartogenin-conjugated polyurethane nano-particles and transforming growth factor β3 for in-situ cartilage regeneration.Mater Sci Eng C Mater Biol Appl. 2020 May;110:110705. doi: 10.1016/j.msec.2020.110705. Epub 2020 Jan 28. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32204019
-
Temporal activation of β-catenin signaling in the chondrogenic process of mesenchymal stem cells affects the phenotype of the cartilage generated.Stem Cells Dev. 2012 Jul 20;21(11):1966-76. doi: 10.1089/scd.2011.0376. Epub 2012 Jan 17. Stem Cells Dev. 2012. PMID: 22133004 Free PMC article.
-
Recent advances in kartogenin for cartilage regeneration.J Drug Target. 2019 Jan;27(1):28-32. doi: 10.1080/1061186X.2018.1464011. Epub 2018 May 30. J Drug Target. 2019. PMID: 29772932 Review.
-
Nanomedicine-Driven Approaches for Kartogenin Delivery: Advancing Chondrogenic Differentiation and Cartilage Regeneration in Tissue Engineering.Int J Nanomedicine. 2025 Jun 13;20:7443-7468. doi: 10.2147/IJN.S525580. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40535835 Free PMC article. Review.
Cited by
-
Application of kartogenin for the treatment of cartilage defects: current practice and future directions.RSC Adv. 2024 Oct 21;14(45):33206-33222. doi: 10.1039/d4ra06558a. eCollection 2024 Oct 17. RSC Adv. 2024. PMID: 39434994 Free PMC article. Review.
-
Gelatin reduced Graphene Oxide Nanosheets as Kartogenin Nanocarrier Induces Rat ADSCs Chondrogenic Differentiation Combining with Autophagy Modification.Materials (Basel). 2021 Feb 24;14(5):1053. doi: 10.3390/ma14051053. Materials (Basel). 2021. PMID: 33668133 Free PMC article.
-
In Situ Deposition of Drug and Gene Nanoparticles on a Patterned Supramolecular Hydrogel to Construct a Directionally Osteochondral Plug.Nanomicro Lett. 2023 Nov 17;16(1):18. doi: 10.1007/s40820-023-01228-w. Nanomicro Lett. 2023. PMID: 37975889 Free PMC article.
-
Transforming growth factor-beta stimulates human bone marrow-derived mesenchymal stem/stromal cell chondrogenesis more so than kartogenin.Sci Rep. 2020 May 20;10(1):8340. doi: 10.1038/s41598-020-65283-8. Sci Rep. 2020. PMID: 32433527 Free PMC article.
-
Research Progress on Stem Cell Therapies for Articular Cartilage Regeneration.Stem Cells Int. 2021 Feb 12;2021:8882505. doi: 10.1155/2021/8882505. eCollection 2021. Stem Cells Int. 2021. PMID: 33628274 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials